Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 67

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Recombinant human interleukin-1 receptor antagonist protects mice against acute doxorubicin-induced cardiotoxicity

Zhu, Jinzhou, Zhang, Jing, Xiang, Di, Zhang, Zhonghui, Zhang, Lin, Wu, Mingyuan, Zhu, Shunying, Zhang, Ruiyan, Han, Wei · 2010 · European Journal of Pharmacology

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ejphar.2010.06.024

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 27

  1. Abbate, 2008, Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction, Circulation, 117, 2670, 10.1161/CIRCULATIONAHA.107.740233 · DOI · Paper page
  2. Arola, 2000, Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis, Cancer Res., 60, 1789
  3. Berthiaume, 2007, Adriamycin-induced oxidative mitochondrial cardiotoxicity, Cell Biol. Toxicol., 23, 15, 10.1007/s10565-006-0140-y · DOI · Paper page
  4. Bertinchant, 2003, Evaluation of cardiac troponin I and T levels as markers of myocardial damage in doxorubicin-induced cardiomyopathy rats, and their relationship with echocardiographic and histological findings, Clin. Chim. Acta, 329, 39, 10.1016/S0009-8981(03)00013-5 · doi:10.1016/s0009-8981(03)00013-5
  5. Bujak, 2009, The role of IL-1 in the pathogenesis of heart disease, Arch. Immunol. Ther. Exp (Warsz)., 57, 165, 10.1007/s00005-009-0024-y · DOI · Paper page
  6. Chen, 2006, Redox proteomic identification of oxidized cardiac proteins in adriamycin-treated mice, Free Rad. Biol. Med., 41, 1470, 10.1016/j.freeradbiomed.2006.08.006 · DOI
  7. Childs, 2002, Doxorubicin treatment in vivo causes cytochrome c release and cardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutase activity, and Bcl-2: Bax ratio, Cancer Res., 62, 4592
  8. Del Rio, 2005, A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress, Nutr. Metab. Cardiovasc. Dis., 15, 316, 10.1016/j.numecd.2005.05.003 · DOI · Paper page
  9. Dinarello, 1996, Biologic basis for interleukin-1 in disease, Blood, 87, 2095, 10.1182/blood.V87.6.2095.bloodjournal8762095 · DOI · Paper page
  10. Gabellec, 1997, Analysis of brain mRNA by reverse transcription-polymerase chain reaction and hybridization with digoxigenin-labeled DNA probe, Brain Res., 2, 145
  11. Horan, 2006, Anthracycline cardiotoxicity, Eur. Heart J., 27, 1137, 10.1093/eurheartj/ehi702 · doi:10.1093/eurheartj/ehi702
  12. Hori, 2009, Oxidative stress and left ventricular remodelling after myocardial infarction, Cardiovasc. Res., 81, 457, 10.1093/cvr/cvn335 · DOI · Paper page
  13. Ikonomidis, 2008, Inhibition of interleukin-1 by anakinra improves vascular and left ventricular function in patients with rheumatoid arthritis, Circulation, 117, 2662, 10.1161/CIRCULATIONAHA.107.731877 · DOI · Paper page
  14. Ing, 1999, Modulation of cytokine-induced cardiac myocyte apoptosis by nitric oxide, bak, and bcl-x, Circ. Res., 84, 21, 10.1161/01.RES.84.1.21 · DOI · Paper page
  15. Kalyanaraman, 2002, Doxorubicin-induced apoptosis: implications in cardiotoxicity, Mol. Cell. Biochem., 234–235, 119, 10.1023/A:1015976430790 · DOI · Paper page
  16. Kusuoka, 1991, Alterations of intracellular calcium homeostasis and myocardial energetics in acute adriamycin-induced heart-failure, J. Cardiovasc. Pharmacol., 18, 437, 10.1097/00005344-199109000-00017 · DOI
  17. Lim, 2002, Local expression of interleukin-1 receptor antagonist by plasmid DNA improves mortality and decreases myocardial inflammation in experimental coxsachieviral myocarditis, Circulation, 105, 1278, 10.1161/circ.105.11.1278 · DOI
  18. Mann, 2002, Inflammatory mediators and the failing heart: past, present, and the foreseeable future, Circ. Res., 91, 988, 10.1161/01.RES.0000043825.01705.1B · DOI · Paper page
  19. Minotti, 1999, Role of iron in anthracycline cardiotoxicity: new tunes for an old song?, FASEB J., 13, 199, 10.1096/fasebj.13.2.199 · DOI · Paper page
  20. O'Brien, 2006, Cardiac troponin I is a sensitive, specific biomarker of cardiac injury in laboratory animals, Lab. Anim., 40, 153, 10.1258/002367706776319042 · DOI · Paper page
  21. Singal, 1998, Doxorubicin-induced cardiomyopathy, N. Engl. J. Med., 339, 900, 10.1056/NEJM199809243391307 · DOI · Paper page
  22. Steinherz, 1991, Cardiac toxicity 4 to 20years after completing anthracycline therapy, JAMA, 266, 672, 10.1001/jama.266.12.1672 · doi:10.1001/jama.266.12.1672
  23. Suzuki, 2001, Overexpression of interleukin-1 receptor antagonist provides cardioprotection against ischemia–reperfusion injury associated with reduction of apoptosis, Circulation, 104, 308, 10.1161/hc37t1.094871 · DOI · Paper page
  24. Temma, 1997, Ca2+ overloading causes the negative inotropic effect of doxorubicin in myocytes isolated from guinea-pig hearts, Eur. J. Pharmacol., 19, 235, 10.1016/S0014-2999(96)00994-6 · doi:10.1016/s0014-2999(96)00994-6
  25. Torti, 1986, Cardiotoxicity of epirubicin and doxorubicin: assessment by endomyocardial biopsy, Cancer Res., 46, 3722
  26. Young, 1981, The anthracycline antineoplastic drugs, N. Engl. J. Med., 305, 139, 10.1056/NEJM198107163050305 · DOI · Paper page
  27. Zhang, 2008, Interleukin-1 receptor antagonist inhibits normal hematopoiesis and reduces lethality and bone marrow toxicity of 5-fluouracil in mouse, Biomed. Pharmacother., 63, 501, 10.1016/j.biopha.2008.09.014 · DOI

Cited by

See all 67

Metadata

Authors
Zhu, J., Zhang, J., Xiang, D., Zhang, Z., Zhang, L., Wu, M., Zhu, S., Zhang, R., & Han, W.
Venue
European Journal of Pharmacology
Publisher
Elsevier BV
Published
2010-09
Volume
643
Issue
2-3
Pages
247-253
ISSN
0014-2999
Cited by
67
References
1
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.